In MR analyses, genetically higher plasma retinol concentrations were associated with risk of stroke but not with MI or T2D; genetically higher plasma RBP4 concentrations were not associated with any of the investigated cardiometabolic end points. Here, RBP4 is linked to type 2 diabetes mellitus.